147 related articles for article (PubMed ID: 31184419)
21. [Treatment failure in children with acute myelocytic leukemia: over 25-year experience of Polish Pediatric Leukemia/Lymphoma Study Group with four consecutive unified treatment protocols for childhood acute myelocytic leukemia].
Dłuzniewska A; Balwierz W; Balcerska A; Chybicka A; Kamieńska E; Karolczyk G; Karpińska-Derda I; Krawczuk-Rybak M; Kowalczyk JR; Lewandowska D; Maciejka-Kapuścińska L; Kołtano S; Malinowska I; Matysiak M; Mikołajczyk M; Mizia-Malarz A; Muszyńska-Rosłan K; Niedźwiedzki M; Pohorecka J; Sikorska-Fic B; Sobol G; Sońta-Jakimczyk D; Tomaszewska R; Urasiński T; Wachowiak J; Wieczorek M; Wójcik B; Wysocki M
Przegl Lek; 2010; 67(6):366-70. PubMed ID: 21344763
[TBL] [Abstract][Full Text] [Related]
22. Comparative Toxicity by Sex Among Children Treated for Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group.
Meeske KA; Ji L; Freyer DR; Gaynon P; Ruccione K; Butturini A; Avramis VI; Siegel S; Matloub Y; Seibel NL; Sposto R
Pediatr Blood Cancer; 2015 Dec; 62(12):2140-9. PubMed ID: 26173904
[TBL] [Abstract][Full Text] [Related]
23. Barriers to Care and Outcomes of Pediatric Acute Lymphoblastic Leukemia Treatment in the Gaza Strip.
Mills D; Abushanab S; Elhaloul A; El Nuweiry H; Shbair M; Qaddoumi I; Salman Z
J Pediatr Hematol Oncol; 2022 Jan; 44(1):e123-e126. PubMed ID: 34705357
[TBL] [Abstract][Full Text] [Related]
24. Identifying causes of variability in outcomes in children with acute lymphoblastic leukemia treated in a resource-rich developing country.
Jastaniah W; Elimam N; Abdalla K; Iqbal BA; Khattab TM; Felimban S; Abrar MB
Pediatr Blood Cancer; 2015 Jun; 62(6):945-50. PubMed ID: 25557583
[TBL] [Abstract][Full Text] [Related]
25. The Impact of Prospective Telemedicine Implementation in the Management of Childhood Acute Lymphoblastic Leukemia in Recife, Brazil.
Pedrosa F; Shaikh F; Rivera G; Ribeiro R; Qaddoumi I
Telemed J E Health; 2017 Oct; 23(10):863-867. PubMed ID: 28422613
[TBL] [Abstract][Full Text] [Related]
26. Treatment of childhood acute lymphoblastic leukemia in Iraq: a 17-year experience from a single center.
Al-Hadad SA; Al-Jadiry MF; Ghali HH; Al-Badri SAF; Al-Saeed RM; Al-Darraji AF; Sabhan AH; Fadhil SA; Hussein HM; Abed WM; Ameen NA; Sahan JKA; Jaafar GQ; Abed AR; Mohamed S; Moleti ML; Piciocchi A; Foà R; Testi AM
Leuk Lymphoma; 2021 Dec; 62(14):3430-3439. PubMed ID: 34355644
[TBL] [Abstract][Full Text] [Related]
27. Long-term follow-up of patients with newly diagnosed adult acute lymphoblastic leukemia: a single institution experience of 378 consecutive patients over a 21-year period.
Thomas X; Danaïla C; Le QH; Sebban C; Troncy J; Charrin C; Lhéritier V; Michallet M; Magaud JP; Fiere D
Leukemia; 2001 Dec; 15(12):1811-22. PubMed ID: 11753600
[TBL] [Abstract][Full Text] [Related]
28. The long-term results of childhood acute lymphoblastic leukemia at two centers from Turkey: 15 years of experience with the ALL-BFM 95 protocol.
Güneş AM; Oren H; Baytan B; Bengoa SY; Evim MS; Gözmen S; Tüfekçi O; Karapınar TH; Irken G
Ann Hematol; 2014 Oct; 93(10):1677-84. PubMed ID: 24863691
[TBL] [Abstract][Full Text] [Related]
29. Relapsed childhood acute lymphoblastic leukemia in the Nordic countries: prognostic factors, treatment and outcome.
Oskarsson T; Söderhäll S; Arvidson J; Forestier E; Montgomery S; Bottai M; Lausen B; Carlsen N; Hellebostad M; Lähteenmäki P; Saarinen-Pihkala UM; Jónsson ÓG; Heyman M;
Haematologica; 2016 Jan; 101(1):68-76. PubMed ID: 26494838
[TBL] [Abstract][Full Text] [Related]
30. The burden of leukemia in the Kingdom of Saudi Arabia: 15 years period (1999-2013).
Bawazir A; Al-Zamel N; Amen A; Akiel MA; Alhawiti NM; Alshehri A
BMC Cancer; 2019 Jul; 19(1):703. PubMed ID: 31315607
[TBL] [Abstract][Full Text] [Related]
31. Outcome of Pediatric Acute Lymphoblastic Leukemia: Sixty Years of Progress.
Demidowicz E; Pogorzała M; Łęcka M; Żołnowska H; Marjańska A; Kubicka M; Kuryło-Rafińska B; Czyżewski K; Dębski R; Kołtan A; Richert-Przygońska M; Styczyński J
Anticancer Res; 2019 Sep; 39(9):5203-5207. PubMed ID: 31519634
[TBL] [Abstract][Full Text] [Related]
32. The Impact of Socioeconomic Factors on the Outcome of Childhood Acute Lymphoblastic Leukemia (ALL) Treatment in a Low/Middle Income Country (LMIC).
Jabeen K; Ashraf MS; Iftikhar S; Belgaumi AF
J Pediatr Hematol Oncol; 2016 Nov; 38(8):587-596. PubMed ID: 27467375
[TBL] [Abstract][Full Text] [Related]
33. Acute lymphoblastic leukemia and Down syndrome: presenting features and treatment outcome in the experience of the Italian Association of Pediatric Hematology and Oncology (AIEOP).
Arico M; Ziino O; Valsecchi MG; Cazzaniga G; Baronci C; Messina C; Pession A; Santoro N; Basso G; Conter V;
Cancer; 2008 Aug; 113(3):515-21. PubMed ID: 18521927
[TBL] [Abstract][Full Text] [Related]
34. Treatment of acute lymphoblastic leukaemia in countries with limited resources; lessons from use of a single protocol in India over a twenty year period [corrected].
Magrath I; Shanta V; Advani S; Adde M; Arya LS; Banavali S; Bhargava M; Bhatia K; Gutiérrez M; Liewehr D; Pai S; Sagar TG; Venzon D; Raina V
Eur J Cancer; 2005 Jul; 41(11):1570-83. PubMed ID: 16026693
[TBL] [Abstract][Full Text] [Related]
35. Relapse of childhood acute lymphoblastic leukemia and outcomes at a reference center in Latin America: organomegaly at diagnosis is a significant clinical predictor.
Jaime-Pérez JC; Pinzón-Uresti MA; Jiménez-Castillo RA; Colunga-Pedraza JE; González-Llano Ó; Gómez-Almaguer D
Hematology; 2018 Jan; 23(1):1-9. PubMed ID: 28580844
[TBL] [Abstract][Full Text] [Related]
36. Adolescents with acute lymphoblastic leukemia treated at pediatric versus adult hospitals.
Pole JD; Alibhai SM; Ethier MC; Teuffel O; Portwine C; Zelcer S; Johnston DL; Silva M; Alexander S; Brandwein JM; Sung L
Ann Oncol; 2013 Mar; 24(3):801-6. PubMed ID: 23108950
[TBL] [Abstract][Full Text] [Related]
37. Volume-Outcome Relationships in Pediatric Acute Lymphoblastic Leukemia: Association Between Hospital Pediatric and Pediatric Oncology Volume With Mortality and Intensive Care Resources During Initial Therapy.
Wilkes JJ; Hennessy S; Xiao R; Rheingold S; Seif AE; Huang YS; Vendetti N; Li Y; Bagatell R; Aplenc R; Fisher BT
Clin Lymphoma Myeloma Leuk; 2016 Jul; 16(7):404-410.e1. PubMed ID: 27246140
[TBL] [Abstract][Full Text] [Related]
38. Causes of Inferior Outcome in Adolescents and Young Adults with Acute Lymphoblastic Leukemia: Across Oncology Services and Regardless of Clinical Trial Enrollment.
Wolfson JA; Richman JS; Sun CL; Landier W; Leung K; Smith EP; O'Donnell M; Bhatia S
Cancer Epidemiol Biomarkers Prev; 2018 Oct; 27(10):1133-1141. PubMed ID: 30262597
[No Abstract] [Full Text] [Related]
39. Intrathecal dose intensification by CNS status at diagnosis in the treatment of children with acute lymphoblastic leukemia.
Jastaniah W; Elimam N; Abdalla K; AlAzmi AA; Algamal A; Felimban S
Hematology; 2019 Dec; 24(1):369-377. PubMed ID: 30885098
[TBL] [Abstract][Full Text] [Related]
40. Supportive medical care for children with acute lymphoblastic leukemia in low- and middle-income countries.
Ceppi F; Antillon F; Pacheco C; Sullivan CE; Lam CG; Howard SC; Conter V
Expert Rev Hematol; 2015 Oct; 8(5):613-26. PubMed ID: 26013005
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
